Neonatal Apnea Treatment Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: February 18, 2021 |

The global neonatal apnea treatment market size is accounted to grow at a significant CAGR of 3.2% during the forecast period 2021 to 2027 and expected to reach USD 296 million by 2027. The increasing incidence of neonatal apnea in preborn children across the globe is a primary factor to drive the market growth. According to the information shared by the American Academy of Pediatrics (AAP), around 70% of children born before 34 weeks of gestation suffer from neonatal apnea.

Moreover, neonatal apnea treatment is a major concern for pediatric surgeons engaged in the provision of neonatal intensive care. Bradycardia is considered clinically important in newborns if the heartbeat is slowed to 30 bpm below the resting heart rate. Furthermore, the effective implementation of treatment guidelines related to the management and care of neonatal intensive units across the globe is expected to fuel the market growth over the forecast period.

Market Segment Insights:

The global neonatal apnea treatment market is bifurcated into drug class, distribution channel, and geography. On the basis of drug class, the market is further divided into aminophylline, theophylline, and caffeine citrate. The caffeine citrate segment is accounted to hold the largest market share. The drug is preferred by pediatric surgeons across the globe for successful extubation in preborn babies, which is major factor to drive the segment growth. Aminophylline is considered as an alternative methylxanthine for the treatment of neonatal apnea due to its ability to improve the contraction of thoracic musculature in newborns who are at risk of suffering from bronchopulmonary dysplasia.

By distribution channel, the neonatal apnea treatment market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacy segment held the largest market share and expected to grow at the same trend over the forecast period. Due to the side effects associated with methyxanthines drug such as nervousness, restlessness, loss of appetite, the hospital makes it mandatory for accurate drug delivery of methacanthin drugs under the supervision of a pharmacist.

Neonatal Apnea Treatment Market Size & Growth

For more information, request a report sample

The neonatal apnea treatment comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

Historical & Forecast Period:

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Neonatal Apnea Treatment Market Segmentation:

By Drug Class:

  • Aminophylline
  • Theophylline
  • Caffeine Citrate

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

Geographically, the neonatal apnea treatment market report comprises dedicated sections centering on the regional market revenue and trends. The neonatal apnea treatment market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The neonatal apnea treatment market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Neonatal apnea treatment market estimates have also been provided for the historical years 2018 & 2019 along with forecasts for the period from 2021 – 2027.

Market Competition Assessment:

Key players operating in the global neonatal apnea treatment market are Omega Laboratories Ltd., Pfizer, Inc. , Merck KGaA, GlaxoSmithKline, Plc., and Sandoz, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Omega Laboratories Ltd.
  • Pfizer, Inc.
  • Merck KGaA
  • GlaxoSmithKline, Plc.
  • Sandoz, Inc.
  • Chiesi Farmaceutici
  • Easton Biopharmaceuticals.
  • Furen Pharmaceutical
  • Fresenius Kabi
  • Mylan Pharmaceutical Industries Limited

Key Questions Answered by Neonatal Apnea Treatment Market Report:

  • Global neonatal apnea treatment market forecasts from 2021-2027
  • Regional neonatal apnea treatment market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Neonatal apnea treatment submarket forecasts from 2021-2027 covering the market by drug class, by distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to neonatal apnea treatment market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level neonatal apnea treatment markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the neonatal apnea treatment market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Neonatal Apnea Treatment Market Portraiture
2.2. Global Neonatal Apnea Treatment Market, by Drug Class, 2020 (USD Mn)
2.3. Global Neonatal Apnea Treatment Market, by Distribution Channel, 2020 (USD Mn)
2.4. Global Neonatal Apnea Treatment Market, by Geography, 2020 (USD Mn)

 

3. Global Neonatal Apnea Treatment Market Analysis


3.1. Neonatal Apnea Treatment Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

 

4. Global Neonatal Apnea Treatment Market By Drug Class, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Aminophylline
4.3. Theophylline
4.4. Caffeine Citrate

 

5. Global Neonatal Apnea Treatment Market By Distribution Channel, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. Others

 

6. North America Neonatal Apnea Treatment Market Analysis and Forecast, 2018 – 2027 (USD Mn)


6.1.1. Overview
6.1.2. North America Neonatal Apnea Treatment Market by Drug Class (2018-2027 USD Mn)
6.1.3. North America Neonatal Apnea Treatment Market by Distribution Channel (2018-2027 USD Mn)
6.1.4. North America Neonatal Apnea Treatment Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.2. Canada

 

7. Europe Neonatal Apnea Treatment Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. Europe Neonatal Apnea Treatment Market by Drug Class (2018-2027 USD Mn)
7.1.3. Europe Neonatal Apnea Treatment Market by Distribution Channel (2018-2027 USD Mn)
7.1.4. Europe Neonatal Apnea Treatment Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.2. U.K.
7.1.4.3. France
7.1.4.4. Italy
7.1.4.5. Rest of Europe

 

8. Asia Pacific Neonatal Apnea Treatment Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Asia Pacific Neonatal Apnea Treatment Market by Drug Class (2018-2027 USD Mn)
8.1.3. Asia Pacific Neonatal Apnea Treatment Market by Distribution Channel (2018-2027 USD Mn)
8.1.4. Asia Pacific Neonatal Apnea Treatment Market by Country (2018-2027 USD Mn)
8.1.4.1. China.
8.1.4.2. Japan
8.1.4.3. Rest of Asia Pacific

 

9. Latin America (LATAM) Neonatal Apnea Treatment Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Latin America Neonatal Apnea Treatment Market by Drug Class (2018-2027 USD Mn)
9.1.3. Latin America Neonatal Apnea Treatment Market by Distribution Channel (2018-2027 USD Mn)
9.1.4. Latin America Neonatal Apnea Treatment Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.2. Mexico
9.1.4.3. Rest of Latin America

 

10. Middle East and Africa Neonatal Apnea Treatment Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. MEA Neonatal Apnea Treatment Market by Drug Class (2018-2027 USD Mn)
10.1.3. MEA Neonatal Apnea Treatment Market by Distribution Channel (2018-2027 USD Mn)
10.1.4. Middle East and Africa Neonatal Apnea Treatment Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.2. Rest of MEA

 

11. Company Profiles


11.1. Omega Laboratories Ltd.
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Pfizer, Inc.
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. Merck KGaA
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. GlaxoSmithKline, Plc.
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Sandoz, Inc.
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. Chiesi Farmaceutici
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Easton Biopharmaceuticals.
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Furen Pharmaceutical
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Fresenius Kabi
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. Mylan Pharmaceutical Industries Limited
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis

For more information, request a report sample

List of Tables:

TABLE 1 Market Snapshot: Global Neonatal Apnea Treatment Market

TABLE 2 Impact Indicators

TABLE 3 Impact Analysis of Drivers and Challenges

TABLE 4 Global Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 5 Global Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 6 North America Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 7 North America Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 8 North America Neonatal Apnea Treatment Market Value, By Country, 2018 - 2027 (US$ Mn)

TABLE 9 U.S. Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 10 U.S. Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 11 Canada Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 12 Canada Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 13 Europe Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 14 Europe Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 15 Europe Neonatal Apnea Treatment Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 16 Germany Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 17 Germany Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 18 U.K. Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 19 U.K. Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 20 France Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 21 France Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 22 Italy Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 23 Italy Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 24 Rest of Europe Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 25 Rest of Europe Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 26 Asia Pacific Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 27 Asia Pacific Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 28 Asia Pacific Neonatal Apnea Treatment Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 29 Japan Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 30 Japan Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 31 China Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 32 China Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 33 Rest of Asia Pacific Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 34 Rest of Asia Pacific Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 35 Latin America Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 36 Latin America Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 37 Latin America Neonatal Apnea Treatment Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 38 Brazil Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 39 Brazil Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 40 Mexico Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 41 Mexico Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 42 Rest of Latin America Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 43 Rest of Latin America Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 44 Middle East & Africa Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 45 Middle East & Africa Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 46 Middle East & Africa Neonatal Apnea Treatment Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 47 GCC Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 48 GCC Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 49 Rest of MEA Neonatal Apnea Treatment Market Value, by Drug Class, 2018 - 2027 (US$ Mn)

TABLE 50 Rest of MEA Neonatal Apnea Treatment Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 51 Omega Laboratories Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 52 Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 53 Merck KGaA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 54 GlaxoSmithKline, Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 55 Sandoz, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 56 Chiesi Farmaceutici: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 57 Easton Biopharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 58 Furen Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 59 Fresenius Kabi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 60 Mylan Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

For more information, request a report sample

List of Figures:

FIG. 1 Global Neonatal Apnea Treatment: Market Segmentation

FIG. 2 Global Neonatal Apnea Treatment Market: Research Methodology

FIG. 3 Top-Down and Bottom-up Approach

FIG. 4 Global Neonatal Apnea Treatment Market, by Drug Class, 2019 (US$ Mn)

FIG. 5 Global Neonatal Apnea Treatment Market, by Distribution Channel, 2019 (US$ Mn)

FIG. 6 Global Neonatal Apnea Treatment Market, by Geography, 2019 (US$ Mn)

FIG. 7 Global Neonatal Apnea Treatment Market Value and Growth, 2018 – 2027, (US$ Mn) (Y-o-Y %)

FIG. 8 Attractive Investment Proposition, by Geography, 2017

FIG. 9 Market Positioning of Key Neonatal Apnea Treatment Providers, 2019

FIG. 10 Global Neonatal Apnea Treatment Market Value Share, by Drug Class, 2018 & 2027 (%)

FIG. 11 Global Neonatal Apnea Treatment Market Value for Aminophylline, 2018 - 2027, (US$ Mn)

FIG. 12 Global Neonatal Apnea Treatment Market Value for Theophylline, 2018 - 2027, (US$ Mn)

FIG. 13 Global Neonatal Apnea Treatment Market Value for Caffeine Citrate, 2018 - 2027, (US$ Mn)

FIG. 14 Global Neonatal Apnea Treatment Market Value Share, by Distribution Channel, 2018 & 2027 (Value %)

FIG. 15 Global Neonatal Apnea Treatment Market Value for Hospital Pharmacy, 2018 - 2027, (US$ Mn)

FIG. 16 Global Neonatal Apnea Treatment Market Value for Retail Pharmacy, 2018 - 2027, (US$ Mn)

FIG. 17 Global Neonatal Apnea Treatment Market Value for Others, 2018 - 2027, (US$ Mn)

FIG. 18 North America Neonatal Apnea Treatment Market Value, 2018 - 2027, (US$ Mn)

FIG. 19 Europe Neonatal Apnea Treatment Market Value, 2018 - 2027, (US$ Mn)

FIG. 20 Asia Pacific Neonatal Apnea Treatment Market Value, 2018 - 2027, (US$ Mn)

FIG. 21 LATIN America Neonatal Apnea Treatment Market Value, 2018 - 2027, (US$ Mn)

FIG. 22 Middle East & Africa Neonatal Apnea Treatment Market Value, 2018 - 2027, (US$ Mn)
Fill the given form to inquiry before buying for Neonatal Apnea Treatment Market Report

Your Designtaion (required):


(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying
Select License Type
$3200/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Neonatal Apnea Treatment Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients